This report contains market size and forecasts of Allergy Rhinitis Drugs in global, including the following market information:
- Global Allergy Rhinitis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Allergy Rhinitis Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Allergy Rhinitis Drugs companies in 2021 (%)
The global Allergy Rhinitis Drugs market was valued at 18010 million in 2021 and is projected to reach US$ 22680 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Capsule Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Allergy Rhinitis Drugs include GlaxoSmithKline, Sanofi, ALK-Abell?, Meda Pharmaceuticals, Adamis Pharmaceuticals, Allergy Therapeutics, Almirall, Ampio and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Allergy Rhinitis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Allergy Rhinitis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Allergy Rhinitis Drugs Market Segment Percentages, by Type, 2021 (%)
- Capsule
- Propellant
- Others
Global Allergy Rhinitis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Allergy Rhinitis Drugs Market Segment Percentages, by Application, 2021 (%)
- Antihistamines
- Intranasal Corticosteroids
- Immunotherapies
- Others
Global Allergy Rhinitis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Allergy Rhinitis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Allergy Rhinitis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Allergy Rhinitis Drugs revenues share in global market, 2021 (%)
- Key companies Allergy Rhinitis Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
- Key companies Allergy Rhinitis Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GlaxoSmithKline
- Sanofi
- ALK-Abell?
- Meda Pharmaceuticals
- Adamis Pharmaceuticals
- Allergy Therapeutics
- Almirall
- Ampio
- AstraZeneca
- Amneal Pharmaceuticals
- Anergis
